The sequential use of endocrine treatment for advanced breast cancer: where are we?
Author:
Funder
AstraZeneca
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/23/6/1378/405898/mdr593.pdf
Reference70 articles.
1. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer;Huang;J Clin Pathol,2005
2. High-dose estrogen and clinical selective estrogen receptor modulators induce growth arrest, p21, and p53 in primate ovarian surface epithelial cells;Wright;J Clin Endocrinol Metab,2005
3. Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment;Howell;J Clin Oncol,2002
4. Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer;Ingle;N Engl J Med,1981
5. Second-line and subsequent therapy for ovarian carcinoma;Peethambaram;Curr Oncol Rep,2002
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance;Cells;2022-05-18
2. A BIRC5High COD1Low Cancer Tissue Phenotype Indicates Poorer Prognosis of Metastatic Breast Cancer Patients;Cancer Informatics;2022-01
3. Bone Health and Cancer Therapy;New Horizons in Osteoporosis Management;2022
4. Meta-analyses of phase 3 randomised controlled trials of third generation aromatase inhibitors versus tamoxifen as first-line endocrine therapy in postmenopausal women with hormone receptor-positive advanced breast cancer;European Journal of Cancer;2021-03
5. Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer;Future Science OA;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3